search
Back to results

Physiotherapy Treatment With Capacitive Resistive Monopolar Radiofrecuency in Young Women With Dyspareunia ([CRMRF])

Primary Purpose

Dyspareunia; Female

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Physical therapy modalities on pelvic floor (manual therapy)
CRMRF
Sham CRMRF
Sponsored by
Escoles Universitaries Gimbernat
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dyspareunia; Female focused on measuring Capacitive Resistive Monopolar Radiofrecuency, Sexual Dysfunction, Physiological, Pelvic floor, Physical Therapy Modalities, Musculoskeletal Manipulations

Eligibility Criteria

18 Years - 30 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Women between 18 and 30 years old. Women who have pain during sexual intercourse, classified as dyspareunia superficial in the last 12 months. Exclusion Criteria: Use of antidepressants. Pregnancy and lactation. Cardiac pathologies. Epilepsy. Acute inflammatory process. Pacemaker. Skin or mucous infections in the urogenital area. Any alteration that prevents the understanding of the informed consent.

Sites / Locations

  • Escoles Universitaries Gimbernat

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Treatment Group

Sham Group

Arm Description

CRMRF and physical therapy modalities on pelvic floor.

Only physical therapy modalities on pelvic floor. In this Arm the CRMRF is off.

Outcomes

Primary Outcome Measures

Pain in sexual intercourse
The pain was described using the anamnesis, the pain score of the "FSFI" scale (Female Sexual Function Index) and the scale of pain "VAS" (Visual Analogue Scale) that is a numerical rating scale that goes from zero to ten. Zero represents the absence of pain and ten the greatest pain that the patient can imagine. The pain was described also using vaginal dilators and seeing at which measure the pain begins.

Secondary Outcome Measures

Female sexual function
The female sexual function was described using the "FSFI" (Female Sexual Function Index) and the "FSM" (Women's Sexual Function).
Quality of sexual relations
The quality of sexual relations was described using the scale "VAS" (Visual Analogue Scale) that is a numerical rating scale that goes from zero to ten. Zero represents the absence of quality of sexual relations and ten the best quality of sexual relations that the patient can imagine, the score of satisfaction of the "FSFI" (Female Sexual Function Index) and the score of "FSM" (Women's Sexual Function).
Problems with vaginal penetration
The problems with vaginal penetration were described using the scale "FSM" (Women's Sexual Function).
State of the musculature of the pelvic floor
The state of the musculature of the pelvic floor was described using the physical exploration of the patient and a device called "EPI-No" that can detect pain by stretching.
Perception of treatment
The perception of treatment was described using specific questions in the anamnesis.

Full Information

First Posted
April 25, 2023
Last Updated
April 25, 2023
Sponsor
Escoles Universitaries Gimbernat
search

1. Study Identification

Unique Protocol Identification Number
NCT05844189
Brief Title
Physiotherapy Treatment With Capacitive Resistive Monopolar Radiofrecuency in Young Women With Dyspareunia
Acronym
[CRMRF]
Official Title
Physiotherapy Treatment With Capacitive Resistive Monopolar Radiofrecuency in Young Women With Dyspareunia
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
November 5, 2021 (Actual)
Primary Completion Date
February 9, 2023 (Actual)
Study Completion Date
February 9, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Escoles Universitaries Gimbernat

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The hypothesis of this study is that capacitive-resistive monopolar radiofrecuency (CRMRF) with vaginal manual physiotherapy improves sexual health in young women suffering from dyspareunia (pain during sexual intercourse). The realization of studies that help to know the therapeutic possibilities in the field of dyspareunia seems necessary, taking into account the number of women affected, as well as the deficits of scientific evidence in this field. The main objective of this study is to analyze whether the use of CRMRF brings additional benefits to the results of manual therapy on dyspareunia in young women. Likewise, it intends to analyze the data for two secondary objectives: Analyze changes in different areas of women's sexual function in young people with dyspareunia through treatment (Desire, arousal, lubrication, orgasm, satisfaction and pain). Study if the use of CRMRF is an added benefit in personal perception while receiving treatment.
Detailed Description
After being informed of the study objectives, inclusion and exclusion criteria, and study methodology, all patients have signed informed consents. The participation of women in this study is entirely voluntary and if, during the course of the study, a participant decides to withdraw, she can do it freely at the time she considers appropriate, without the need to give explanations. At week 0, patients who meet the eligibility requirements will be randomized using "Random.org" in a single-blind manner (participant) in two Arms: Treatment Group (CRMRF and physical therapy modalities on pelvic floor) Sham Group (only physical therapy modalities on pelvic floor). There will be 4 identical treatment sessions (one each week). These sessions are protocolized. Data collection will be carried out before the first session, after the last session and 12 weeks after the end of the treatment. The approximate duration of each session is 40 minutes. Sessions with data collection will be approximately between 45 minutes to 1 hour. During the first visit, patients will be asked to answer a series of questions and respond to some questionnaires (FSFI, Female Sexual Function Index and FSM, Women's Sexual Function). The results of the different tests carried out, as well as all the documentation referring to the participants, are totally confidential and will only be available to the main researcher, the collaborators and the health authorities competent, if applicable. All necessary security measures so that study participants are not identified and confidentiality measures in all cases will be complete, in accordance with Regulation 2016/679 of the European Parliament and of the Council of April 27, 2016 on the + protection of natural persons (RGPD) and Organic Law 3/2018, of December 5, Protection of Personal Data and Guarantee of Digital Rights (LOPD-GDD). During treatment, the patient will be placed in the supine position for the treatment, in litotonic position, because in this position the abdominal muscles and coxofemoral joints will be relaxed. The manual therapy techniques in the two groups will be based on Thiele's perineal massage, which consists of a massage from the origin to the insertion of the levator anus muscle with an amount of pressure tolerable by the patient. The maneuver will be performed by performing a back and forth movement over the entire palpable surface of muscle. CRMRF will be performed on the treatment group with two types of active electrodes that, throughout the treatment, will be kept moving to avoid heat concentration. An external capacitive electrode, flat, stainless steel and coated with polyamide of 3cm diameter (ECE), which will act on the superficial tissues, skin, mucosa and muscle. It will be used externally bordering the external vaginal lips while the physiotherapist performs the perineal massage with the other hand. An internal, cylindrical, stainless steel resistive electrode, 8 cm long and 1.5 cm in diameter (ERI). It has a plastic screw-on cap to prevent heat concentration. The application will be endocavitary, in direct contact with the intravaginal tissue of the woman. Throughout all the treatment the patient will have a passive electrode on her back, which will be a rectangular return plate. To perform the treatment, an Intradermik equipment (Rös's Estética), a conductive gel (Clear Ultrasound Gel, OXD Professional Care, REF US-C1) and the 2 different types of electrodes are used. Participants will be blinded. As a masking technique, patients will be told that the intervention can produce a sensation of increased temperature in the area of application but that it does not always have to occur. Placing of the device will not allow participants to see the monitor. In the Sham Group, the CRMRF device is off. The data obtained as study variables will be coded during the study, processed and analyzed.The sample population to be used in the analyses will include all participants who meet all inclusion criteria, except those who have decided to leave the study before its completion. Statistical analysis will be performed with IBM SPSS Statistics (v20) software to assess the primary and secondary objectives and hypotheses of the study, including: Tests of normality of the variables. Analysis of the description variables of the complete sample: percentages, contingency tables, descriptive statistics (mean, standard deviation, median, minimum and maximum). Analysis of the sample description variables, by groups: percentages, contingency tables, descriptive statistics (mean, standard deviation, median, minimum and maximum). Comparison of means in related samples, separated by groups: T-test for mean difference (variables with normal distribution) and non-parametric Wilcoxon test (variables with non-normal distribution). The following comparisons are made: Final - Initial, ReTest - Final, ReTest - Initial. Comparison of means between groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyspareunia; Female
Keywords
Capacitive Resistive Monopolar Radiofrecuency, Sexual Dysfunction, Physiological, Pelvic floor, Physical Therapy Modalities, Musculoskeletal Manipulations

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
44 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment Group
Arm Type
Experimental
Arm Description
CRMRF and physical therapy modalities on pelvic floor.
Arm Title
Sham Group
Arm Type
Sham Comparator
Arm Description
Only physical therapy modalities on pelvic floor. In this Arm the CRMRF is off.
Intervention Type
Procedure
Intervention Name(s)
Physical therapy modalities on pelvic floor (manual therapy)
Intervention Description
Intravaginal treatment (perineal massage)
Intervention Type
Device
Intervention Name(s)
CRMRF
Intervention Description
CRMRF application on pelvic floor: Externally over the urogenital triangle of the patient, Intracavitary application (intravaginal) Externally over the urogenital triangle of the patient while the physical therapist performs the intracavitary manual therapy (intravaginal), The device used is named "Intradermik" and it is the portable CRMRF device of the brand RÖS'S Estética SL. It has these features: Frequency: 448kHz Capacitive power: 450 voltamperes Resistive power: 200 watts
Intervention Type
Device
Intervention Name(s)
Sham CRMRF
Intervention Description
The physical therapist applies the same treatment as the Treatment Group but the device is switched off.
Primary Outcome Measure Information:
Title
Pain in sexual intercourse
Description
The pain was described using the anamnesis, the pain score of the "FSFI" scale (Female Sexual Function Index) and the scale of pain "VAS" (Visual Analogue Scale) that is a numerical rating scale that goes from zero to ten. Zero represents the absence of pain and ten the greatest pain that the patient can imagine. The pain was described also using vaginal dilators and seeing at which measure the pain begins.
Time Frame
Five months
Secondary Outcome Measure Information:
Title
Female sexual function
Description
The female sexual function was described using the "FSFI" (Female Sexual Function Index) and the "FSM" (Women's Sexual Function).
Time Frame
Five months
Title
Quality of sexual relations
Description
The quality of sexual relations was described using the scale "VAS" (Visual Analogue Scale) that is a numerical rating scale that goes from zero to ten. Zero represents the absence of quality of sexual relations and ten the best quality of sexual relations that the patient can imagine, the score of satisfaction of the "FSFI" (Female Sexual Function Index) and the score of "FSM" (Women's Sexual Function).
Time Frame
Five months
Title
Problems with vaginal penetration
Description
The problems with vaginal penetration were described using the scale "FSM" (Women's Sexual Function).
Time Frame
Five months
Title
State of the musculature of the pelvic floor
Description
The state of the musculature of the pelvic floor was described using the physical exploration of the patient and a device called "EPI-No" that can detect pain by stretching.
Time Frame
Five months
Title
Perception of treatment
Description
The perception of treatment was described using specific questions in the anamnesis.
Time Frame
Five months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women between 18 and 30 years old. Women who have pain during sexual intercourse, classified as dyspareunia superficial in the last 12 months. Exclusion Criteria: Use of antidepressants. Pregnancy and lactation. Cardiac pathologies. Epilepsy. Acute inflammatory process. Pacemaker. Skin or mucous infections in the urogenital area. Any alteration that prevents the understanding of the informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anna Abelló Pla, MSc
Organizational Affiliation
Escoles Universitaries Gimbernat
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jordi Esquirol Caussa, PhD
Organizational Affiliation
Escoles Universitaries Gimbernat
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Judit Lleberia
Organizational Affiliation
Universitat Autònoma de Barcelona
Official's Role
Study Director
Facility Information:
Facility Name
Escoles Universitaries Gimbernat
City
Sant Cugat Del Vallès
State/Province
Barcelona
ZIP/Postal Code
08174
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29913665
Citation
Thomten J. Living with genital pain: Sexual function, satisfaction, and help-seeking among women living in Sweden. Scand J Pain. 2014 Jan 1;5(1):19-25. doi: 10.1016/j.sjpain.2013.10.002.
Results Reference
result
PubMed Identifier
19140047
Citation
Elmerstig E, Wijma B, Swahnberg K. Young Swedish women's experience of pain and discomfort during sexual intercourse. Acta Obstet Gynecol Scand. 2009;88(1):98-103. doi: 10.1080/00016340802620999.
Results Reference
result
PubMed Identifier
25345486
Citation
Hendrickx L, Gijs L, Enzlin P. Age-related prevalence rates of sexual difficulties, sexual dysfunctions, and sexual distress in heterosexual women: results from an online survey in flanders. J Sex Med. 2015 Feb;12(2):424-35. doi: 10.1111/jsm.12725. Epub 2014 Oct 27.
Results Reference
result
PubMed Identifier
28120373
Citation
Mitchell KR, Geary R, Graham CA, Datta J, Wellings K, Sonnenberg P, Field N, Nunns D, Bancroft J, Jones KG, Johnson AM, Mercer CH. Painful sex (dyspareunia) in women: prevalence and associated factors in a British population probability survey. BJOG. 2017 Oct;124(11):1689-1697. doi: 10.1111/1471-0528.14518. Epub 2017 Jan 25.
Results Reference
result
PubMed Identifier
26410801
Citation
Demirel G, Golbasi Z. Effect of perineal massage on the rate of episiotomy and perineal tearing. Int J Gynaecol Obstet. 2015 Nov;131(2):183-6. doi: 10.1016/j.ijgo.2015.04.048. Epub 2015 Jul 26.
Results Reference
result
PubMed Identifier
28391147
Citation
Leon-Larios F, Corrales-Gutierrez I, Casado-Mejia R, Suarez-Serrano C. Influence of a pelvic floor training programme to prevent perineal trauma: A quasi-randomised controlled trial. Midwifery. 2017 Jul;50:72-77. doi: 10.1016/j.midw.2017.03.015. Epub 2017 Mar 27.
Results Reference
result
PubMed Identifier
26906970
Citation
Takeuchi S, Horiuchi S. Randomised controlled trial using smartphone website vs leaflet to support antenatal perineal massage practice for pregnant women. Women Birth. 2016 Oct;29(5):430-435. doi: 10.1016/j.wombi.2016.01.010. Epub 2016 Feb 19.
Results Reference
result
PubMed Identifier
28759286
Citation
Spottorno J, Gonzalez de Vega C, Buenaventura M, Hernando A. Influence of electrodes on the 448 kHz electric currents created by radiofrequency: A finite element study. Electromagn Biol Med. 2017;36(3):306-314. doi: 10.1080/15368378.2017.1354015. Epub 2017 Jul 31.
Results Reference
result
PubMed Identifier
28027568
Citation
Silva AP, Montenegro ML, Gurian MB, Mitidieri AM, Lara LA, Poli-Neto OB, Rosa E Silva JC. Perineal Massage Improves the Dyspareunia Caused by Tenderness of the Pelvic Floor Muscles. Rev Bras Ginecol Obstet. 2017 Jan;39(1):26-30. doi: 10.1055/s-0036-1597651. Epub 2016 Dec 27.
Results Reference
result
PubMed Identifier
26524223
Citation
Kumaran B, Watson T. Thermal build-up, decay and retention responses to local therapeutic application of 448 kHz capacitive resistive monopolar radiofrequency: A prospective randomised crossover study in healthy adults. Int J Hyperthermia. 2015;31(8):883-95. doi: 10.3109/02656736.2015.1092172. Epub 2015 Nov 2.
Results Reference
result
PubMed Identifier
34135723
Citation
Trahan J, Leger E, Allen M, Koebele R, Yoffe MB, Simon C, Alappattu M, Figuers C. The Efficacy of Manual Therapy for Treatment of Dyspareunia in Females: A Systematic Review. J Womens Health Phys Therap. 2019 Jan-Mar;43(1):28-35. doi: 10.1097/jwh.0000000000000117.
Results Reference
result
PubMed Identifier
32197978
Citation
Sanchez-Sanchez F, Ferrer-Casanova C, Ponce-Buj B, Sipan-Sarrion Y, Jurado-Lopez AR, San Martin-Blanco C, Tijeras-Ubeda MJ, Ferrandez Infante A. [Design and validation of the second edition of the Women's Sexual Function Questionnaire, FSM-2]. Semergen. 2020 Jul-Aug;46(5):324-330. doi: 10.1016/j.semerg.2020.01.004. Epub 2020 Mar 18. Spanish.
Results Reference
result
PubMed Identifier
32033334
Citation
Sanchez-Sanchez B, Navarro-Brazalez B, Arranz-Martin B, Sanchez-Mendez O, de la Rosa-Diaz I, Torres-Lacomba M. The Female Sexual Function Index: Transculturally Adaptation and Psychometric Validation in Spanish Women. Int J Environ Res Public Health. 2020 Feb 5;17(3):994. doi: 10.3390/ijerph17030994. Erratum In: Int J Environ Res Public Health. 2020 Jun 17;17(12):
Results Reference
result
PubMed Identifier
10782451
Citation
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. doi: 10.1080/009262300278597.
Results Reference
result
PubMed Identifier
32441260
Citation
Fernandez-Cuadros ME, Kazlauskas SG, Albaladejo-Florin MJ, Robles-Lopez M, Laborda-Delgado A, de la Cal-Alvarez C, Perez-Moro O. [Effectiveness of multimodal rehabilitation (biofeedback plus capacitive-resistive radiofrequency) on chronic pelvic pain and dyspareunia: prospective study and literature review]. Rehabilitacion (Madr). 2020 Jul-Sep;54(3):154-161. doi: 10.1016/j.rh.2020.02.005. Epub 2020 May 6. Spanish.
Results Reference
result

Learn more about this trial

Physiotherapy Treatment With Capacitive Resistive Monopolar Radiofrecuency in Young Women With Dyspareunia

We'll reach out to this number within 24 hrs